SCNI Margin dodolan resik Scinai

Scinai (SCNI) - logo korporat

Capacity restructuring and high fixed costs are currently limiting the operational efficiency of Scinai Immunotherapeutics (SCNI). Meanwhile, the company is attracting leading NanoAbs researchers through a flexible corporate culture and RSUs. On the GURU.Markets platform, the net margin indicator demonstrates profit dynamics, where -81.60 reflects the metric's baseline. The development strategy is based on creating nanobodies for the therapy of psoriasis and infections.

Rentabilitas dodolan resik BiondVax Pharmaceuticals (SCNI): kanggo periode 21.02.2024 - 20.11.2026

Ringkesan rincian data analitis Scinai Immunotherapeutics (SCNI)

- rega saham lan prakiraan rega para ahli:
Ringkesan analitik perusahaan:Scinai Immunotherapeutics Ltd - SCNI
Barang unggulan BiondVax Pharmaceuticals

The operational efficiency of Scinai Immunotherapeutics (SCNI) is directly reflected in the dynamics of its net profit margin. This metric measures the share of net income in total revenue, demonstrating the business's real-time resilience. The current value of -81.60 confirms the critical dependence of capital on R&D expenditures. In the absence of commercial revenue, the negative trend on the chart highlights a high cash burn rate. This signals investment risks associated with the early stages of biologic drug trials.

Pesaing Scinai Immunotherapeutics (SCNI)

argenx (ARGX) - Margin resik|BNTX - Margin dodolan perusahaan|ABVX (Abivax Pharma) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik ADMA Bio (ADMA)|Rentabilitas dodolan miturut bathi resik PTGX (Protagonist Therapeutics Inc)|Margin dodolan resik immunovant.com (IMVT)|Margin resik kiniksa.com KNSA|Grifols SA (GRFS) - Margin resik|Adaptive Biotechnologies Inc. - Margin dodolan resik|Margin resik Celldex Therapeutics|AUPH: Margin dodolan resik|BCRX - Margin dodolan perusahaan|VERA (Vera Corp) - Margin dodolan resik|Dianthus Pharma (DNTH) - Margin dodolan perusahaan|Margin resik Pharvaris Pharma (PHVS)|Margin dodolan resik AbCellera Corp (ABCL)|Margin dodolan resik TRML (Tourmaline Bio Inc)|Margin dodolan perusahaan precigen.com (PGEN)|PHAR - Margin resik|Tingkat bathi resik NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Rentabilitas dodolan miturut bathi resik|Zenas Corp (ZBIO) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik IMNM|GOSS: Tingkat bathi resik|Margin resik KalVista Pharma (KALV)|SEPN - Margin resik|Margin dodolan resik PVLA (pieris.com)|Margin dodolan resik Savara Pharma SVRA|RIGL: Rentabilitas dodolan miturut bathi resik|ANAB - Margin dodolan resik|ATXS: Margin dodolan resik|ENGN - Margin dodolan perusahaan|Rentabilitas dodolan miturut bathi resik RAPT|JBIO (Aerovate Therapeutics Inc) - Rentabilitas resik perusahaan|Margin dodolan resik ACRS|Rentabilitas dodolan miturut bathi resik kyvernatx.com KYTX|Margin dodolan resik TLSA (Tiziana Life Sciences, Ltd.)|Margin dodolan resik Cabaletta Bio CABA|VTYX: Rentabilitas dodolan miturut bathi resik|Theratechnologies Inc. (THTX) - Rentabilitas dodolan miturut bathi resik|AVTX: Margin dodolan resik|ELDN - Margin dodolan perusahaan|AGEN (Agenus, Inc) - Margin dodolan resik|Margin dodolan resik Climb Bio, Inc.|Margin resik Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Tingkat bathi resik|Margin dodolan resik ADAG (Adagene Inc)|IMA - Rentabilitas dodolan miturut bathi resik|STTK - Margin resik|EQ (equilliumbio.com) - Rentabilitas dodolan resik|CNTB: Margin dodolan resik|Immunic Inc (IMUX) - Margin dodolan resik|ATRA (Atara Biotherapeutics Inc) - Margin dodolan resik|Rentabilitas dodolan resik IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Tingkat bathi resik|Adicet Bio, Inc. - Rentabilitas dodolan resik|Celularity Inc - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik INmune Bio Corporation INMB|Barinthus Biotherapeutics - Margin dodolan resik|Kezar Life Sciences, Inc. (KZR) - Rentabilitas dodolan miturut bathi resik|SAB Biotherapeutics Inc. (SABS) - Margin resik|Rentabilitas dodolan miturut bathi resik Akari Therapeutics plc|Margin resik enlivex.com|q32bio.com (QTTB) - Margin dodolan perusahaan|Margin dodolan resik GOVX|Edesa Biotech, Inc. - Rentabilitas dodolan resik|iBio Inc - Rentabilitas dodolan miturut bathi resik|Margin dodolan resik Carisma Therapeutics CARM|XTLB - Margin resik|BOLT (boltbio.com) - Rentabilitas dodolan resik|HCWB: Margin dodolan resik|Aptevo (APVO) - Margin dodolan resik|Margin resik AIM ImmunoTech|Rentabilitas dodolan miturut bathi resik Aditxt (ADTX)|Rentabilitas dodolan miturut bathi resik GRI (GRI Bio Corporation)|XORTX - Rentabilitas dodolan resik|Margin dodolan resik HIND (Vyome Holdings Inc.)|Tingkat bathi resik REVB|Indaptus - Margin dodolan resik|CALI (calcimedica.com) - Rentabilitas dodolan resik|AFMD (Affimed Therapeutics) - Rentabilitas dodolan miturut bathi resik|Allakos Therapeutics (ALLK) - Margin dodolan resik|HOOK (HOOKIPA) - Margin dodolan resik|igmbio.com (IGMS) - Margin dodolan perusahaan|Margin dodolan resik ITOS|OCEA (Ocean Biomedical) - Tingkat bathi resik|Margin dodolan resik TCBP (TC BioPharm (Holdings) PLC)|THRD - Rentabilitas dodolan miturut bathi resik